Report Library
View More
Acute Lymphoblastic Leukemia KOL In...
March 31, 2026
Acute Lymphoblastic Leukemia KOL In...
March 31, 2026
Acute Lymphoblastic Leukemia KOL In...
March 30, 2026
Acute Lymphoblastic Leukemia KOL In...
March 30, 2026
Datamonitor Healthcare CV&Met: Veno...
March 10, 2026
Datamonitor Healthcare CV&Met: Atri...
March 10, 2026
Datamonitor Healthcare Oncology: Sm...
March 10, 2026
Datamonitor Healthcare I&I: Glaucom...
March 10, 2026
Bio Asia 2026 Conference Dispatch
March 9, 2026
Datamonitor Healthcare CV&Met: Isch...
March 4, 2026
Datamonitor Healthcare CV&Met: Chem...
March 4, 2026
Datamonitor Healthcare Other: Erect...
March 4, 2026
Datamonitor Healthcare Other: Hypog...
March 4, 2026
Datamonitor Healthcare CV&Met: Amyl...
March 4, 2026
Datamonitor Healthcare Oncology: Tu...
March 4, 2026
Datamonitor Healthcare CNS: Neuropa...
March 4, 2026
Datamonitor Healthcare Oncology: Me...
March 4, 2026
Cystic Fibrosis (CF) KOL Interview ...
March 2, 2026
Neuroendocrine Tumors (NET) KOL Int...
March 1, 2026
Neuroendocrine Tumors (NET) KOL Int...
March 1, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 3/30/26 | Bristol Myers Squibb (BMY) | Camzyos for Cardiomyopathy - Hypertrophic | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/29/26 | Merck & Co. (MRK) | Winrevair for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/27/26 | BioNTech (BNTX) | gotistobart for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/26/26 | Maze Therapeutics (MAZE) | MZE829 for Chronic Kidney Disease (CKD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/23/26 | Apogee Therapeutics (APGE) | APG777 for Atopic Dermatitis (Eczema) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |